Royalty Pharma (RPRX) Stock Overview

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

RPRX Stock Information

Symbol

RPRX

Address

110 East 59th StreetNew York, NY 10022United States

Founded

Trading hours

9:30 AM - 4:00 PM ET

Website

https://www.royaltypharma.com

Country

🇺🇸 United States

Phone Number

212 883 0200

Royalty Pharma (RPRX) Price Chart

Royalty Pharma Overview: Key Details and Summary

Stock data	2023	Change
Price	$28.21	N/A
Market Cap	$12.63B	N/A
Shares Outstanding	447.60M	2.20%
Employees	0	N/A
Shareholder Equity	10.08B	5.87%

Valuation	2023	Change
P/E Ratio	11.15	N/A
P/S Ratio	5.36	N/A
P/B Ratio	1.25	N/A
P/FCF	4.23	N/A

Dividends	2023	Change
Dividend Yield	2.84%	N/A
Dividend per share	0.8006	N/A
Dividend Payout Ratio	0.2108	N/A

Growth	2023	Change
ROIC	0.3452	N/A
Return on Equity	0.1686	N/A

Earnings	2023	Change
Revenue	$2.35B	N/A
Earnings	$1.70B	N/A
Free Cash Flow	$2.99B	N/A
EPS	2.53	N/A
Earnings Yield	0.0897	N/A
Operating Margin	0.6337	N/A
Net income margin	0.722	N/A
FCF Margin	1.27	N/A

Financial Strength	2023	Change
Total Assets	$16.38B	N/A
Cash on Hand	$1.23B	N/A
Debt to Equity	0.6245	-18.38%
Current Ratio	$7.90	260.59%

Other data	2023	Change
Buyback Yield	0.0241	N/A